FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1482311000001107: Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
24756301000001119 Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
63686201000001119 Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet 3 x 7 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Is a Co-amoxiclav 500mg/125mg tablets 21 tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Is pack of Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has active ingredient Amoxicillin trihydrate false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has active ingredient Amoxicillin false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has active ingredient Clavulanate potassium false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has AMP Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has specific active ingredient Clavulanate potassium true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has specific active ingredient Amoxicillin trihydrate true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Discontinued indicator Re-marketed false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has basis of strength substance Clavulanic acid true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Has basis of strength substance Amoxicillin true Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Co-amoxiclav 500mg/125mg tablets (Ranbaxy (UK) Ltd) 21 tablet Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start